CDCA8 and its multifaceted role in tumorigenesis.
Boming Peng1, Jianquan Zhang2, Yang Xiang2
1Department of Hepatobiliary Surgery, Haikou Affiliated Hospital of Central South University Xiangya School of Medicine, Haikou 570208, China.
Summary
Human cell division cycle-associated 8 (CDCA8) is crucial for cell division and is upregulated in many cancers, driving tumor progression. Targeting CDCA8 offers potential for cancer diagnosis, treatment, and prognosis.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- Human cell division cycle-associated 8 (CDCA8), also known as Borealin, is a key component of the Chromosomal Passenger Complex (CPC).
- CDCA8 is vital for accurate sister chromatid segregation and cytokinesis, preventing aneuploidy.
- Aberrant CDCA8 expression is linked to various human cancers, including liver, lung, glioma, and bladder cancers.
Purpose of the Study:
- To review the critical roles of CDCA8 in cancer diagnosis, treatment, and prognosis.
- To elucidate the mechanisms by which CDCA8 influences tumor progression.
- To highlight CDCA8 as a potential biomarker and therapeutic target.
Main Methods:
- Literature review of studies on CDCA8 function in cell division and cancer.
- Analysis of CDCA8 expression patterns in various cancer types.
- Examination of signaling pathways modulated by CDCA8 in tumorigenesis.
Main Results:
- CDCA8 upregulation promotes cancer progression by affecting cell proliferation, apoptosis, invasion, and metastasis.
- CDCA8 expression levels correlate with tumor stage and grade, indicating prognostic value.
- CDCA8 modulates key cancer-related pathways such as P53, PI3K/Akt, E2F/Rb, and mTOR.
Conclusions:
- CDCA8 is a significant factor in cancer development and progression across multiple tumor types.
- CDCA8 serves as a promising biomarker for cancer diagnosis and prognosis.
- Targeting CDCA8 presents a potential therapeutic strategy for various cancers.
Related Concept Videos
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
M-Cdk Drives Transition Into Mitosis
5.5K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.5K
Anaphase Promoting Complex
2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
